May 23, 2017 / 8:01 AM / 2 months ago

BRIEF-Mithra Pharmaceuticals receives GMP approval for Myring production

1 Min Read

May 23 (Reuters) - MITHRA PHARMACEUTICALS SA:

* Mithra Receives Gmp Approval for Myring Production

* APPROVAL ENSURES MITHRA FULLY PREPARED TO SHIP FIRST COMMERCIAL BATCHES IN EUROPE

* ON TRACK TO FILE FOR MARKETING APPROVAL OF HORMONAL CONTRACEPTIVE MYRING IN EU AND US IN Q2 2017

* MYRING’S ORIGINATOR PRODUCT, NUVARING, WILL GO OFF PATENT IN APRIL 2018, ALLOWING OTHER PRODUCTS, SUCH AS MYRING, TO ENTER US AND EUROPEAN MARKET Source text: bit.ly/2q5Xn5A Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below